Xylazine Wounds: Why Detox Includes Real Wound Care

If you have an open sore and you’ve been using street fentanyl, the question on your mind probably isn’t a medical one. It’s whether you can walk into a treatment center without being stared at, lectured, or turned away. Here’s the direct answer: a licensed medical detox can treat xylazine wounds and opioid withdrawal at the same time, and you do not have to get the wound under control before you ask for help. Waiting for skin to heal on its own before starting treatment is the one plan that reliably makes both problems worse.

The other thing worth saying plainly, because almost nobody says it: these wounds are not a hygiene problem, and they’re not evidence that someone was careless. Xylazine restricts blood flow to the skin, and skin without enough blood supply breaks down and struggles to repair itself. That’s a drug-supply problem that arrived in the fentanyl people were already buying. The care that follows should be built around that fact.

Key Takeaways

• Xylazine wounds come from restricted blood flow to the skin, not from poor hygiene or careless injecting.
• The sores can appear far from any injection site, including in people who smoke or snort rather than inject.
• Untreated wounds can lead to deep infection, bloodstream infection, and permanent tissue loss.
• Naloxone does not reverse xylazine, but you should still give it during a suspected overdose because opioids are almost always present too.
• Wound care and withdrawal management belong in the same setting, at the same time, under supervision.

What Xylazine Changed About The Street Supply

Xylazine is a veterinary sedative that was never approved for people. Over the past several years, it has been mixed into the illicit opioid supply across much of the country, usually alongside fentanyl and usually without the buyer knowing. Federal surveillance published in the CDC’s Morbidity and Mortality Weekly Report tracked xylazine showing up in a growing share of fentanyl-involved overdose deaths across 21 jurisdictions, rising from 2.9% to 10.9% of those deaths between January 2019 and June 2022.

That figure is worth reading carefully, because it’s often quoted as though it were current. It isn’t. It covers a window that closed in mid-2022, and it remains the most recent multi-jurisdiction federal count of its kind. National overdose deaths have fallen substantially since then, but xylazine did not leave the supply when the death toll started dropping. It’s now a settled feature of the drug supply. Clinicians in South Florida have documented confirmed xylazine wound cases locally, including a 2024 case report describing a patient whose skin damage appeared in areas well away from where he’d been injecting. The background on how tranq reached Florida’s fentanyl supply fills in the rest of that story.

Why Xylazine Wounds Form In The First Place

Xylazine is an alpha-2 adrenergic agonist. In plain terms, it tells small blood vessels in the skin to tighten. When those vessels constrict, less oxygenated blood reaches the tissue they feed. Skin that’s chronically short on blood supply starts to break down, and once it breaks down, it can’t run the normal repair process either, because repair also depends on circulation.

Clinical reviews of xylazine toxicity describe this as vasoconstriction at peripheral alpha-2b receptors leading to decreased skin perfusion, and note that tissue samples show dead skin layers and small clots in surface vessels without the inflammation you’d expect from an infection-driven process. In other words, the damage starts as a circulation problem, and infection arrives afterward through skin that has already lost its barrier.

A few consequences follow from that mechanism:

• The wounds develop slowly and then stall because healing needs the same blood flow the drug limits.
• They can keep worsening even when someone is keeping the area clean.
• They don’t respond like a simple abscess, so ordinary approaches fall short.
• They tend to recur in the same regions when exposure continues.

What Makes Xylazine Wounds Different From Other Injection Wounds

Anyone who has injected drugs for a while has seen the usual complications: a tender red lump, a pocket of pus, a spreading patch of warmth. Those are infections. They start with bacteria, they respond to drainage and antibiotics, and they follow a predictable arc.

Xylazine wounds behave differently. They begin as tissue dying from lack of blood, which means the tissue is already compromised before any germ gets involved. That difference matters for treatment, because draining and treating an infection doesn’t restore circulation to skin that isn’t getting enough. It’s also why these wounds can look alarming while the person feels relatively well, and why they can deepen over weeks rather than days.

Three practical differences show up again and again:

1. Location. Ordinary injection infections sit where the needle went. Xylazine sores often don’t.
2. Depth over time. If exposure continues and nothing is done, they can progress through the skin into the soft tissue underneath.
3. Healing pace. They close slowly and need consistent care over weeks, not a single visit.

Why The Wounds Show Up Where You Never Injected

This is the part that confuses people most, and it’s the part that most clearly clears the person of blame. Because xylazine affects blood vessels systemically rather than locally, poor perfusion isn’t confined to one puncture site. The National Institute on Drug Abuse notes that the sores can appear at an injection site but often appear elsewhere on the body, and that clinicians have reported wounds in people who smoke or snort xylazine and never inject it at all.

That last detail deserves emphasis. If someone can develop these wounds without ever using a needle, then the wounds can’t be explained by injection technique, reused equipment, or how clean somebody was. The drug is doing this through the bloodstream. Anyone told otherwise, including by a clinician, was told something the evidence doesn’t support.

Why Xylazine Wounds Turn Dangerous When They Go Untreated

Left alone, these wounds don’t stay cosmetic. Skin is the body’s main barrier against infection, and a wound that stays open through compromised tissue remains an open entry point. The clinical literature on xylazine toxicity lists the serious outcomes directly: bacteremia, endocarditis, sepsis, limb amputation, and death.

The FDA has alerted health care professionals to the risk of severe, necrotic skin ulcerations from repeated xylazine exposure, and warns that these wounds can become infected and, without treatment, lead to amputation. None of that is inevitable. It’s what happens when a wound that needs clinical care doesn’t get any, usually because the person couldn’t face another appointment where they’d be judged.

Signs that a wound needs to be seen urgently rather than at some point include:

• Spreading redness, swelling, or warmth beyond the wound edges
• Fever, chills, confusion, or a racing heartbeat
• A foul smell, dark tissue, or the wound suddenly getting deeper
• Pain that climbs sharply or numbness in the limb
• Any exposed tissue below the skin

Those signs point toward emergency care, not toward waiting to see whether it settles.

Naloxone Still Matters Even Though It Doesn’t Reverse Xylazine

Xylazine isn’t an opioid, so naloxone doesn’t act on it. That fact has been misread into a dangerous conclusion: that naloxone is pointless if tranq might be involved. The opposite is true. Xylazine rarely appears alone, and the opioid mixed with it is usually the thing stopping someone’s breathing.

NIDA’s guidance is to give naloxone anyway, because xylazine overdoses almost always include opioids and other drugs. The FDA gives the same instruction to clinicians: keep administering naloxone for a suspected opioid overdose, and consider xylazine exposure when someone doesn’t respond as expected. Reversing the opioid part of a mixed overdose still saves lives even when sedation continues.

In practice, that means calling 911, giving naloxone, supporting breathing, and staying with the person, since xylazine sedation can outlast naloxone. Knowing how to respond when someone stops breathing is worth learning before the moment arrives.

What Wound Care Looks Like Inside A Medical Detox

Here’s what integrated care actually means, and why it isn’t just a nicer version of being sent to a clinic across town.

Withdrawal and wound care interfere with each other when you handle them separately. Someone in full opioid withdrawal, with a sedative withdrawal layered on top, cannot sit still for a dressing change, cannot tolerate the pain of wound assessment, and frequently leaves before either problem is addressed. The Philadelphia Consensus on the surgical management of xylazine-associated wounds makes this explicit, calling for a multidisciplinary approach that treats the wound and the underlying substance use disorder together, with pain and withdrawal controlled well enough that the person can actually participate in their own care.

In a licensed medical detox setting, that looks like:

• Clinical assessment of every wound at intake, including how deep it goes and whether infection is present
• Withdrawal managed by medical staff around the clock, so the person is stable enough to tolerate treatment
• Dressing changes performed on a schedule by trained staff, not left to the patient
• Decisions about antibiotics made on evidence, since not every wound needs them
• Escalation to specialist or surgical consultation when a wound is deep enough to require it
• A plan for continuing wound care after detox, so progress doesn’t stop at discharge

Nothing on that list is something to attempt alone at home. Wound assessment, infection decisions, and withdrawal management all require clinical judgment and monitoring. What matters for someone reading this is that the sequence isn’t wound first, then treatment. It’s both, starting the same day. Knowing what actually happens during the detox process takes some of the fear out of walking in.

Shame Is The Barrier, Not The Wound

People delay care for these wounds for reasons unrelated to medicine. They’ve been treated badly in an emergency department before. They’ve had a nurse recoil. They’ve been told to come back when they’re clean. They’ve covered the wound with long sleeves in Florida heat so nobody asks. Published clinical accounts describe exactly this dynamic, noting that people who inject drugs face discrimination inside the health care system that deepens mistrust and pushes them further from care.

That’s a system failure, not a character flaw. And it has a measurable cost in tissue. A wound that would have closed with weeks of consistent care becomes a wound that needs surgery, because the person spent those weeks avoiding a room where they expected to be humiliated.

The encouraging part is what the clinical record shows when care is actually delivered without punishment attached. A 2024 report in Case Reports in Dermatological Medicine documented xylazine wounds improving with consistent management delivered alongside addiction treatment, including in patients who moved through multiple cycles of recovery and return to use. Sobriety wasn’t the entry requirement. Steady care was. Coastal Detox treats wound assessment as part of admission, not as a reason to turn someone away, and the broader work of dismantling the stigma around addiction starts with how a person is met at the door.

Why Going It Alone Is The Riskiest Option

Someone facing both a wound and withdrawal may reason that they’ll handle the withdrawal at home first and deal with the skin later. That plan fails on both counts. Withdrawal from an opioid and sedative combination is medically unpredictable, and attempting it without monitoring leaves nobody watching for the complications that matter. Meanwhile, the wound keeps progressing through tissue that isn’t getting the blood supply it needs.

Supervised care solves both at once because the same team is watching both. The comparison between supervised detox and trying to quit at home is stark for anyone, and it gets starker when there’s an open wound involved. You don’t need to arrive healed. You need to arrive.

References

• Illicitly Manufactured Fentanyl-Involved Overdose Deaths with Detected Xylazine – United States, January 2019-June 2022 – CDC Morbidity and Mortality Weekly Report
• Xylazine Toxicity – StatPearls, National Center for Biotechnology Information
• Xylazine – National Institute on Drug Abuse
• FDA Alerts Health Care Professionals of Risks to Patients Exposed to Xylazine in Illicit Drugs – U.S. Food and Drug Administration
• Philadelphia Consensus on the Surgical Management of Xylazine-Associated Wounds in People Who Use Drugs – SurgiColl
• Treatment of Xylazine-Associated Injection Skin Injuries – Case Reports in Dermatological Medicine